Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients

[1]  A. Moiseev,et al.  In vivo assessment of structural changes of the urethra in lower urinary tract disease using cross-polarization optical coherence tomography , 2020 .

[2]  N. Boulis.  Intrathecal Riluzole for the Treatment of Patients With Amyotrophic Lateral Sclerosis , 2019, Neurosurgery.

[3]  R. Carare,et al.  Dispersion in porous media in oscillatory flow between flat plates: applications to intrathecal, periarterial and paraarterial solute transport in the central nervous system , 2019, Fluids and Barriers of the CNS.

[4]  P. Bede,et al.  Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts—Novel Techniques , 2019, Front. Neurol..

[5]  Lucas R. Sass,et al.  Characterization of intrathecal cerebrospinal fluid geometry and dynamics in cynomolgus monkeys (macaca fascicularis) by magnetic resonance imaging , 2019, PloS one.

[6]  S. Blackburn,et al.  Novel Dual Lumen Catheter and Filtration Device for Removal of Subarachnoid hemorrhage: First Case Report. , 2018, Operative neurosurgery.

[7]  Jessica a. Cohen,et al.  Prevalence of Amyotrophic Lateral Sclerosis — United States, 2015 , 2018, MMWR. Morbidity and mortality weekly report.

[8]  N. Srinivas,et al.  Two Decades-Long Journey from Riluzole to Edaravone: Revisiting the Clinical Pharmacokinetics of the Only Two Amyotrophic Lateral Sclerosis Therapeutics , 2018, Clinical Pharmacokinetics.

[9]  S. Nagel,et al.  Intrathecal Therapeutics: Device Design, Access Methods, and Complication Mitigation , 2018, Neuromodulation : journal of the International Neuromodulation Society.

[10]  Lefko T. Charalambous,et al.  Novel Treatment of Cryptococcal Meningitis via Neurapheresis Therapy , 2018, The Journal of infectious diseases.

[11]  Francis Loth,et al.  An MRI-Compatible Hydrodynamic Simulator of Cerebrospinal Fluid Motion in the Cervical Spine , 2018, IEEE Transactions on Biomedical Engineering.

[12]  Lucas R. Sass,et al.  Anthropomorphic Model of Intrathecal Cerebrospinal Fluid Dynamics Within the Spinal Subarachnoid Space: Spinal Cord Nerve Roots Increase Steady-Streaming. , 2018, Journal of biomechanical engineering.

[13]  Berislav V. Zlokovic,et al.  Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.

[14]  J. Cohen‐Adad,et al.  Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral Sclerosis , 2018, American Journal of Neuroradiology.

[15]  K. Zakrzewski,et al.  The oscillatory flow of the cerebrospinal fluid in the Sylvian aqueduct and the prepontine cistern measured with phase contrast MRI in children with hydrocephalus—a preliminary report , 2018, Child's Nervous System.

[16]  Lucas R. Sass,et al.  A 3D subject-specific model of the spinal subarachnoid space with anatomically realistic ventral and dorsal spinal cord nerve rootlets , 2017, Fluids and Barriers of the CNS.

[17]  Lynne E Bilston,et al.  Chiari malformation may increase perivascular cerebrospinal fluid flow into the spinal cord: A subject-specific computational modelling study. , 2017, Journal of biomechanics.

[18]  Per Kristian Eide,et al.  Glymphatic MRI in idiopathic normal pressure hydrocephalus , 2017, Brain : a journal of neurology.

[19]  J. Oshinski,et al.  Nonuniform Moving Boundary Method for Computational Fluid Dynamics Simulation of Intrathecal Cerebrospinal Flow Distribution in a Cynomolgus Monkey. , 2017, Journal of biomechanical engineering.

[20]  Is posture-related craniospinal compliance shift caused by jugular vein collapse? A theoretical analysis , 2017, Fluids and Barriers of the CNS.

[21]  J. Oshinski,et al.  Quantifying the influence of respiration and cardiac pulsations on cerebrospinal fluid dynamics using real‐time phase‐contrast MRI , 2017, Journal of magnetic resonance imaging : JMRI.

[22]  M. Saulino,et al.  Best Practices for Intrathecal Baclofen Therapy: Patient Selection , 2016, Neuromodulation : journal of the International Neuromodulation Society.

[23]  R. Henry,et al.  Quantitative MRI of the spinal cord and brain in adrenomyeloneuropathy: in vivo assessment of structural changes. , 2016, Brain : a journal of neurology.

[24]  P. Heath,et al.  The genetics of amyotrophic lateral sclerosis: current insights , 2016, Degenerative neurological and neuromuscular disease.

[25]  Bethany L Peterson,et al.  321 Development of Intrathecal Riluzole: A New Route of Administration for the Treatment of Amyotrophic Lateral Sclerosis Patients. , 2016, Neurosurgery.

[26]  Theresia I. Yiallourou,et al.  Inter-operator Reliability of Magnetic Resonance Image-Based Computational Fluid Dynamics Prediction of Cerebrospinal Fluid Motion in the Cervical Spine , 2016, Annals of Biomedical Engineering.

[27]  M. Oshimura,et al.  Use of a Human Artificial Chromosome for Delivering Trophic Factors in a Rodent Model of Amyotrophic Lateral Sclerosis , 2015, Molecular therapy. Nucleic acids.

[28]  Andreas A. Linninger,et al.  CNS wide simulation of flow resistance and drug transport due to spinal microanatomy. , 2015, Journal of biomechanics.

[29]  M. Nedergaard,et al.  Distinct Functional States of Astrocytes During Sleep and Wakefulness: Is Norepinephrine the Master Regulator? , 2015, Current Sleep Medicine Reports.

[30]  M. Benatar,et al.  Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis , 2014, Muscle & nerve.

[31]  S. Paganoni,et al.  Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. , 2015, NeuroRehabilitation.

[32]  M. Meltzer,et al.  Estimating the future number of cases in the Ebola epidemic--Liberia and Sierra Leone, 2014-2015. , 2014, MMWR supplements.

[33]  W. Robberecht,et al.  Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery , 2014, Expert opinion on investigational drugs.

[34]  S. Rossignol,et al.  Multi-Parametric Spinal Cord MRI as Potential Progression Marker in Amyotrophic Lateral Sclerosis , 2014, PloS one.

[35]  M. França,et al.  Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[36]  J. Oshinski,et al.  Cerebrospinal fluid flow impedance is elevated in Type I Chiari malformation. , 2014, Journal of biomechanical engineering.

[37]  Leah N. Bryan,et al.  Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011. , 2014, MMWR supplements.

[38]  Daniel J. R. Christensen,et al.  Sleep Drives Metabolite Clearance from the Adult Brain , 2013, Science.

[39]  Francis Loth,et al.  Hydrodynamic and Longitudinal Impedance Analysis of Cerebrospinal Fluid Dynamics at the Craniovertebral Junction in Type I Chiari Malformation , 2013, PloS one.

[40]  Lynne E. Bilston,et al.  Computational fluid dynamics modelling of cerebrospinal fluid pressure in Chiari malformation and syringomyelia. , 2013, Journal of biomechanics.

[41]  David C. Zhu,et al.  The Frequency and Magnitude of Cerebrospinal Fluid Pulsations Influence Intrathecal Drug Distribution: Key Factors for Interpatient Variability , 2012, Anesthesia and analgesia.

[42]  K. Abe,et al.  CSF flow dynamics in motor neuron disease , 2012, Neurological research.

[43]  Walter Heindel,et al.  Magnetic resonance 4D flow analysis of cerebrospinal fluid dynamics in Chiari I malformation with and without syringomyelia , 2012, European Radiology.

[44]  D. Fletcher,et al.  The presence of arachnoiditis affects the characteristics of CSF flow in the spinal subarachnoid space: a modelling study. , 2012, Journal of biomechanics.

[45]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[46]  V. Haughton,et al.  Effect of Tonsillar Herniation on Cyclic CSF Flow Studied with Computational Flow Analysis , 2011, American Journal of Neuroradiology.

[47]  Timothy J. Harris,et al.  The Effect of Pulsatile Flow on Intrathecal Drug Delivery in the Spinal Canal , 2011, Annals of Biomedical Engineering.

[48]  O. Hardiman,et al.  Amyotrophic lateral sclerosis , 2011, The Lancet.

[49]  T. Raju,et al.  Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients , 2011, Journal of Neural Transmission.

[50]  Luca A. Finelli,et al.  Understanding pharmacokinetics using realistic computational models of fluid dynamics: biosimulation of drug distribution within the CSF space for intrathecal drugs , 2010, Journal of Pharmacokinetics and Pharmacodynamics.

[51]  Pamela A McCombe,et al.  Effects of gender in amyotrophic lateral sclerosis. , 2010, Gender medicine.

[52]  M. Filippi,et al.  The Present and the Future of Neuroimaging in Amyotrophic Lateral Sclerosis , 2010, American Journal of Neuroradiology.

[53]  O. Lindvall,et al.  Stem cells in human neurodegenerative disorders--time for clinical translation? , 2010, The Journal of clinical investigation.

[54]  I. Joo,et al.  Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice , 2009, Gene Therapy.

[55]  A. L. La Spada,et al.  ALS motor phenotype heterogeneity, focality, and spread , 2009, Neurology.

[56]  Weihua Zhao,et al.  Microglia in ALS: The Good, The Bad, and The Resting , 2009, Journal of Neuroimmune Pharmacology.

[57]  Matthew C Kiernan,et al.  Biomarkers in amyotrophic lateral sclerosis , 2009, The Lancet Neurology.

[58]  J. Oshinski,et al.  MR Measurement of Pulse Wave Velocity in the Spinal Canal , 2008 .

[59]  S. McClelland,et al.  Intrathecal baclofen for spasticity‐related pain in amyotrophic lateral sclerosis: Efficacy and factors associated with pain relief , 2008, Muscle & nerve.

[60]  B. Traynor,et al.  Genetics of sporadic amyotrophic lateral sclerosis. , 2007, Human molecular genetics.

[61]  H. Stockman,et al.  Effect of anatomical fine structure on the dispersion of solutes in the spinal subarachnoid space. , 2007, Journal of biomechanical engineering.

[62]  S. Sadiq,et al.  Long–term intrathecal baclofen therapy in ambulatory patients with spasticity , 2006, Journal of Neurology.

[63]  Francis Loth,et al.  Syringomyelia hydrodynamics: an in vitro study based on in vivo measurements. , 2005, Journal of biomechanical engineering.

[64]  Jeffrey D. Rothstein,et al.  Human Embryonic Germ Cell Derivatives Facilitate Motor Recovery of Rats with Diffuse Motor Neuron Injury , 2003, The Journal of Neuroscience.

[65]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[66]  P. Shaw.  Toxicity of CSF in motor neurone disease: a potential route to neuroprotection. , 2002, Brain : a journal of neurology.

[67]  N Alperin,et al.  Hydrodynamic modeling of cerebrospinal fluid motion within the spinal cavity. , 2000, Journal of biomechanical engineering.

[68]  J. Finsterer,et al.  Cerebrospinal fluid filtration in amyotrophic lateral sclerosis , 1999, European journal of neurology.

[69]  J. Finsterer,et al.  Liquorpheresis (CSF filtration) in familial amyotrophic lateral sclerosis , 1999, Spinal Cord.

[70]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.